Evidence map›Paper›PMID 38658137›Full record

ArticleeNeuro2024

Loss of Midbrain Dopamine Neurons Does Not Alter GABAergic Inhibition Mediated by Parvalbumin-Expressing Interneurons in Mouse Primary Motor Cortex.

Suraj Cherian, Gabriel Simms, Liqiang Chen, Hong-Yuan Chu

Open access · goldAbstract read
In one paragraph

Article in eNeuro, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Dysfunction of motor cortices in Parkinson's disease.Cerebral cortex (New York, N.Y. : 1991) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Suraj CherianDepartment of Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, Michigan 49503.ORCID https://orcid.org/0000-0003-1148-770X
Gabriel SimmsDepartment of Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, Michigan 49503.
Liqiang ChenDepartment of Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, Michigan 49503.
Hong-Yuan ChuDepartment of Neurodegenerative Science, Van Andel Research Institute, Grand Rapids, Michigan 49503 hongyuan.chu@gmail.com.ORCID https://orcid.org/0000-0003-0923-683X
Van Andel Institute · US

Funding

Motor cortical circuitry adaptations in experimental Parkinson's diseaseR01NS121371 · NINDS · VAN ANDEL RESEARCH INSTITUTE · PI CHU, HONG-YUAN · 2021 to 2025
$2.2M
NINDS NIH HHS R01 NS121371
6 · The paper itself

Abstract

The primary motor cortex (M1) integrates sensory and cognitive inputs to generate voluntary movement. Its functional impairments have been implicated in the pathophysiology of motor symptoms in Parkinson's disease (PD). Specifically, dopaminergic degeneration and basal ganglia dysfunction entrain M1 neurons into the abnormally synchronized bursting pattern of activity throughout the cortico-basal ganglia-thalamocortical network. However, how degeneration of the midbrain dopaminergic neurons affects the anatomy, microcircuit connectivity, and function of the M1 network remains poorly understood. The present study examined whether and how the loss of dopamine (DA) affects the morphology, cellular excitability, and synaptic physiology of Layer 5 parvalbumin-expressing (PV

Indexed as

Dopaminergic NeuronsInterneuronsMesencephalonMotor CortexParvalbuminsAnimalsFemaleGABAergic NeuronsMaleMiceMice, Inbred C57BLMice, TransgenicNeural InhibitionParvalbumins6-OHDAdopaminemotor cortexoptogeneticsParkinson's diseaseparvalbumin

Identifiers

PMID38658137
PMCPMC11082919
OpenAlexW4395069786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.